TGFB1 and colitis: EPA supplementation effectively mitigates inflammation in acetic acid-induced rat colitis models by modulating the TGF-β/p-EGFR and NF-κB inflammatory pathways, restoring oxidant/antioxidant balance, and enhancing colonic barrier integrity (50).